A citation-based method for searching scientific literature

Nana Weber-Lassalle, Julika Borde, Konstantin Weber-Lassalle, Judit Horváth, Dieter Niederacher, Norbert Arnold, Silke Kaulfuß, Corinna Ernst, Victoria G Paul, Ellen Honisch, Kristina Klaschik, Alexander E Volk, Christian Kubisch, Steffen Rapp, Nadine Lichey, Janine Altmüller, Louisa Lepkes, Esther Pohl-Rescigno, Holger Thiele, Peter Nürnberg, Mirjam Larsen, Lisa Richters, Kerstin Rhiem, Barbara Wappenschmidt, Christoph Engel, Alfons Meindl, Rita K Schmutzler, Eric Hahnen, Jan Hauke. Breast Cancer Res 2019
Times Cited: 23







List of co-cited articles
410 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Fergus J Couch, Hermela Shimelis, Chunling Hu, Steven N Hart, Eric C Polley, Jie Na, Emily Hallberg, Raymond Moore, Abigail Thomas, Jenna Lilyquist,[...]. JAMA Oncol 2017
338
60

Inherited Mutations in Women With Ovarian Carcinoma.
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
399
47

Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.
Susan J Ramus, Honglin Song, Ed Dicks, Jonathan P Tyrer, Adam N Rosenthal, Maria P Intermaggio, Lindsay Fraser, Aleksandra Gentry-Maharaj, Jane Hayward, Susan Philpott,[...]. J Natl Cancer Inst 2015
235
47

BARD1 is A Low/Moderate Breast Cancer Risk Gene: Evidence Based on An Association Study of the Central European p.Q564X Recurrent Mutation.
Malwina Suszynska, Wojciech Kluzniak, Dominika Wokolorczyk, Anna Jakubowska, Tomasz Huzarski, Jacek Gronwald, Tadeusz Debniak, Marek Szwiec, Magdalena Ratajska, Katarzyna Klonowska,[...]. Cancers (Basel) 2019
20
45

Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing.
Hsiao-Mei Lu, Shuwei Li, Mary Helen Black, Shela Lee, Robert Hoiness, Sitao Wu, Wenbo Mu, Robert Huether, Jefferey Chen, Srijani Sridhar,[...]. JAMA Oncol 2019
85
34

Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing.
Hermela Shimelis, Holly LaDuca, Chunling Hu, Steven N Hart, Jie Na, Abigail Thomas, Margaret Akinhanmi, Raymond M Moore, Hiltrud Brauch, Angela Cox,[...]. J Natl Cancer Inst 2018
150
34

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
34

Germline mutations in RAD51D confer susceptibility to ovarian cancer.
Chey Loveday, Clare Turnbull, Emma Ramsay, Deborah Hughes, Elise Ruark, Jessica R Frankum, Georgina Bowden, Bolot Kalmyrzaev, Margaret Warren-Perry, Katie Snape,[...]. Nat Genet 2011
340
30

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
30

Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
513
30

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
30

Identification of a RING protein that can interact in vivo with the BRCA1 gene product.
L C Wu, Z W Wang, J T Tsan, M A Spillman, A Phung, X L Xu, M C Yang, L Y Hwang, A M Bowcock, R Baer. Nat Genet 1996
579
30

Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls.
Jenna Lilyquist, Holly LaDuca, Eric Polley, Brigette Tippin Davis, Hermela Shimelis, Chunling Hu, Steven N Hart, Jill S Dolinsky, Fergus J Couch, David E Goldgar. Gynecol Oncol 2017
63
30

The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.
R Hashizume, M Fukuda, I Maeda, H Nishikawa, D Oyake, Y Yabuki, H Ogata, T Ohta. J Biol Chem 2001
522
30

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.
Thomas P Slavin, Kara N Maxwell, Jenna Lilyquist, Joseph Vijai, Susan L Neuhausen, Steven N Hart, Vignesh Ravichandran, Tinu Thomas, Ann Maria, Danylo Villano,[...]. NPJ Breast Cancer 2017
81
30

The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication.
Madalena Tarsounas, Patrick Sung. Nat Rev Mol Cell Biol 2020
95
30

Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population.
Honglin Song, Ed Dicks, Susan J Ramus, Jonathan P Tyrer, Maria P Intermaggio, Jane Hayward, Christopher K Edlund, David Conti, Patricia Harrington, Lindsay Fraser,[...]. J Clin Oncol 2015
183
26

Hereditary breast and ovarian cancer: new genes in confined pathways.
Finn Cilius Nielsen, Thomas van Overeem Hansen, Claus Storgaard Sørensen. Nat Rev Cancer 2016
205
26

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.
Xin Yang, Goska Leslie, Alicja Doroszuk, Sandra Schneider, Jamie Allen, Brennan Decker, Alison M Dunning, James Redman, James Scarth, Inga Plaskocinska,[...]. J Clin Oncol 2020
136
26

Cancer predisposing BARD1 mutations in breast-ovarian cancer families.
Magdalena Ratajska, Ewelina Antoszewska, Anna Piskorz, Izabela Brozek, Åke Borg, Hanna Kusmierek, Wojciech Biernat, Janusz Limon. Breast Cancer Res Treat 2012
67
26

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
Tom Walsh, Silvia Casadei, Ming K Lee, Christopher C Pennil, Alex S Nord, Anne M Thornton, Wendy Roeb, Kathy J Agnew, Sunday M Stray, Anneka Wickramanayake,[...]. Proc Natl Acad Sci U S A 2011
628
26

Functional analysis of BARD1 missense variants in homology-directed repair and damage sensitivity.
Aleksandra I Adamovich, Tapahsama Banerjee, Margaret Wingo, Kathryn Duncan, Jie Ning, Fernanda Martins Rodrigues, Kuan-Lin Huang, Cindy Lee, Feng Chen, Li Ding,[...]. PLoS Genet 2019
17
35

Dualistic Role of BARD1 in Cancer.
Flora Cimmino, Daniela Formicola, Mario Capasso. Genes (Basel) 2017
35
26

Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.
Fergus J Couch, Steven N Hart, Priyanka Sharma, Amanda Ewart Toland, Xianshu Wang, Penelope Miron, Janet E Olson, Andrew K Godwin, V Shane Pankratz, Curtis Olswold,[...]. J Clin Oncol 2015
403
26

Lifetime cancer risks in individuals with germline PTEN mutations.
Min-Han Tan, Jessica L Mester, Joanne Ngeow, Lisa A Rybicki, Mohammed S Orloff, Charis Eng. Clin Cancer Res 2012
473
21

The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression.
Reena Shakya, Matthias Szabolcs, Ellen McCarthy, Elson Ospina, Katia Basso, Subhadra Nandula, Vundavalli Murty, Richard Baer, Thomas Ludwig. Proc Natl Acad Sci U S A 2008
97
21

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.
Alfons Meindl, Heide Hellebrand, Constanze Wiek, Verena Erven, Barbara Wappenschmidt, Dieter Niederacher, Marcel Freund, Peter Lichtner, Linda Hartmann, Heiner Schaal,[...]. Nat Genet 2010
476
21

No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.
Douglas F Easton, Fabienne Lesueur, Brennan Decker, Kyriaki Michailidou, Jun Li, Jamie Allen, Craig Luccarini, Karen A Pooley, Mitul Shah, Manjeet K Bolla,[...]. J Med Genet 2016
78
21

Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers.
T H Thai, F Du, J T Tsan, Y Jin, A Phung, M A Spillman, H F Massa, C Y Muller, R Ashfaq, J M Mathis,[...]. Hum Mol Genet 1998
145
21

Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations.
Chiara Ghimenti, Elisa Sensi, Silvano Presciuttini, Isa Maura Brunetti, PierFranco Conte, Generoso Bevilacqua, Maria A Caligo. Genes Chromosomes Cancer 2002
86
21

Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.
Rajendra Bahadur Shahi, Sylvia De Brakeleer, Ben Caljon, Ingrid Pauwels, Maryse Bonduelle, Sofie Joris, Christel Fontaine, Marian Vanhoeij, Sonia Van Dooren, Erik Teugels,[...]. BMC Cancer 2019
22
22

Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women.
Allison W Kurian, Elisha Hughes, Elizabeth A Handorf, Alexander Gutin, Brian Allen, Anne-Renee Hartman, Michael J Hall. JCO Precis Oncol 2017
30
21

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Nadine Tung, Chiara Battelli, Brian Allen, Rajesh Kaldate, Satish Bhatnagar, Karla Bowles, Kirsten Timms, Judy E Garber, Christina Herold, Leif Ellisen,[...]. Cancer 2015
287
21

A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
Saundra S Buys, John F Sandbach, Amanda Gammon, Gayle Patel, John Kidd, Krystal L Brown, Lavania Sharma, Jennifer Saam, Johnathan Lancaster, Mary B Daly. Cancer 2017
212
21

Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families.
Laurent Castéra, Valentin Harter, Etienne Muller, Sophie Krieger, Nicolas Goardon, Agathe Ricou, Antoine Rousselin, Germain Paimparay, Angelina Legros, Olivia Bruet,[...]. Genet Med 2018
44
21

New concepts on BARD1: Regulator of BRCA pathways and beyond.
Irmgard Irminger-Finger, Magda Ratajska, Maxim Pilyugin. Int J Biochem Cell Biol 2016
50
21

Oncogenic BARD1 isoforms expressed in gynecological cancers.
Lin Li, Stephan Ryser, Eva Dizin, Dietmar Pils, Michael Krainer, Charles Edward Jefford, Francesco Bertoni, Robert Zeillinger, Irmgard Irminger-Finger. Cancer Res 2007
52
21



BARD1 is necessary for ubiquitylation of nucleosomal histone H2A and for transcriptional regulation of estrogen metabolism genes.
Mikaela D Stewart, Elena Zelin, Abhinav Dhall, Tom Walsh, Esha Upadhyay, Jacob E Corn, Champak Chatterjee, Mary-Claire King, Rachel E Klevit. Proc Natl Acad Sci U S A 2018
27
21

Crystal structure of the BARD1 ankyrin repeat domain and its functional consequences.
David Fox, Isolde Le Trong, Ponni Rajagopal, Peter S Brzovic, Ronald E Stenkamp, Rachel E Klevit. J Biol Chem 2008
32
21

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D.
Xin Yang, Honglin Song, Goska Leslie, Christoph Engel, Eric Hahnen, Bernd Auber, Judit Horváth, Karin Kast, Dieter Niederacher, Clare Turnbull,[...]. J Natl Cancer Inst 2020
56
21

Linkage of early-onset familial breast cancer to chromosome 17q21.
J M Hall, M K Lee, B Newman, J E Morrow, L A Anderson, B Huey, M C King. Science 1990
21

Distinct roles of BARD1 isoforms in mitosis: full-length BARD1 mediates Aurora B degradation, cancer-associated BARD1beta scaffolds Aurora B and BRCA2.
Stephan Ryser, Eva Dizin, Charles Edward Jefford, Bénédicte Delaval, Sarantis Gagos, Agni Christodoulidou, Karl-Heinz Krause, Daniel Birnbaum, Irmgard Irminger-Finger. Cancer Res 2009
64
21

Penetrance of ATM Gene Mutations in Breast Cancer: A Meta-Analysis of Different Measures of Risk.
Monica Marabelli, Su-Chun Cheng, Giovanni Parmigiani. Genet Epidemiol 2016
61
17

Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer.
Johanna I Kiiski, Liisa M Pelttari, Sofia Khan, Edda S Freysteinsdottir, Inga Reynisdottir, Steven N Hart, Hermela Shimelis, Sara Vilske, Anne Kallioniemi, Johanna Schleutker,[...]. Proc Natl Acad Sci U S A 2014
122
17

CHEK2 is a multiorgan cancer susceptibility gene.
C Cybulski, B Górski, T Huzarski, B Masojć, M Mierzejewski, T Debniak, U Teodorczyk, T Byrski, J Gronwald, J Matyjasik,[...]. Am J Hum Genet 2004
342
17

Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.
Bing Xia, Qing Sheng, Koji Nakanishi, Akihiro Ohashi, Jianmin Wu, Nicole Christ, Xinggang Liu, Maria Jasin, Fergus J Couch, David M Livingston. Mol Cell 2006
570
17

Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas.
Kathryn P Pennington, Tom Walsh, Maria I Harrell, Ming K Lee, Christopher C Pennil, Mara H Rendi, Anne Thornton, Barbara M Norquist, Silvia Casadei, Alexander S Nord,[...]. Clin Cancer Res 2014
566
17

BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.
Nana Weber-Lassalle, Jan Hauke, Juliane Ramser, Lisa Richters, Eva Groß, Britta Blümcke, Andrea Gehrig, Anne-Karin Kahlert, Clemens R Müller, Karl Hackmann,[...]. Breast Cancer Res 2018
44
17


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.